Matthew Cowie is a partner in the white collar and securities litigation group in London.
Mr Cowie focuses his practice on white collar matters relating to corruption and fraud, internal corporate investigations and government enforcement matters, defending both companies and individual clients.
Noted as having an "excellent knowledge of the regulatory agencies" (Chambers UK), he also advises on compliance best practices for UK and multi-national corporates, particularly regarding anti-corruption and other corporate governance issues. Mr Cowie has broad industry sector experience, having worked on internal and government investigations, inter alia, in the pharmaceutical; financial institutions; defense; oil & gas; telecoms and aviation sectors.
Prior to moving to private practice at an international law firm in 2010, Mr Cowie served as a lead prosecutor at the UK Serious Fraud Office (SFO). During his eleven years at the SFO, he became known as one of the architects of the UK's early responses to international corruption and he successfully brought a number of landmark cases including:
Mabey & Johnson Ltd (2009), the first corporate conviction for overseas bribery in the UK of a UK company; Johnson & Johnson/DePuy Ltd (2010), the first SFO and DOJ coordinated settlement of charges against the U.S. parent and UK subsidiary for corruption, and the follow on first significant prosecution of a senior corporate executive on corruption charges, both within the medical devices industry; Innospec Ltd (2010), the first truly global coordinated settlement (US$40 million) of significant corruption allegations where the SFO worked alongside the DOJ, the Securities and Exchange Commission (SEC) and the Office of Foreign Assets Control (OFAC) – a case which is widely viewed as a catalyst for establishing the current UK deferred prosecution agreement (DPA) legislation; and BAE Systems plc (2010), a well-known case resulting in a conviction in the UK and a deferred prosecution agreement in the U.S., totaling US$400 million.